Exploring HCN channels as novel drug targets

Nature Reviews Drug Discovery

Volumn 10, Issue 12, 2011, Pages 903-914

  Postea, Otilia ^a   Biel, Martin ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 (N ETHYL N PHENYLAMINO) 1,2 DIMETHYL 6 (METHYLAMINO)PYRIMIDINIUM CHLORIDE; ALINIDINE; CILOBRADINE; CLONIDINE; GABAPEN; GABAPENTIN; HALOTHANE; HYPERPOLARIZATION ACTIVATED CYCLIC NUCLEOTIDE GATED CHANNEL; ION CHANNEL; ISOFLURANE; IVABRADINE; KETAMINE; LAMOTRIGINE; LOPERAMIDE; NICOTINE; OXALIPLATIN; PROPOFOL; UNCLASSIFIED DRUG; ZATEBRADINE;

ANALGESIC ACTIVITY; ANESTHESIA; ANGINA PECTORIS; ARRHYTHMOGENESIS; ATHEROSCLEROSIS; BLOOD RETINA BARRIER; CHANNELOPATHY; COMPLEX FORMATION; CORONARY ARTERY DISEASE; DRUG APPROVAL; DRUG DESIGN; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG RESEARCH; DRUG SAFETY; DRUG STRUCTURE; DRUG TARGETING; EPILEPSY; GENE MUTATION; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART RATE; HUMAN; MOLECULAR PATHOLOGY; MULTICENTER STUDY (TOPIC); NERVE CELL EXCITABILITY; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; NEUROPATHOLOGY; NONHUMAN; OUTCOME ASSESSMENT; PAIN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; STABLE ANGINA PECTORIS; STRUCTURE ACTIVITY RELATION; TACHYCARDIA;

ANALGESICS; ANIMALS; CARDIOVASCULAR DISEASES; CYCLIC NUCLEOTIDE-GATED CATION CHANNELS; DRUG DELIVERY SYSTEMS; HUMANS; NERVE TISSUE PROTEINS; PAIN; POTASSIUM CHANNELS;

EID: 82455199092     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd3576     Document Type: Review

References (146)

1. Biel, M., Wahl-Schott, C., Michalakis, S. & Zong, X. Hyperpolarization-activated cation channels: from genes to function. Physiol. Rev. 89, 847-885 (2009).
2. Robinson, R. B. & Siegelbaum, S. A. Hyperpolarization-activated cation currents: from molecules to physiological function. Annu. Rev. Physiol. 65, 453-480 (2003).
3. Baruscotti, M., Bucchi, A. & Difrancesco, D. Physiology and pharmacology of the cardiac pacemaker ("funny") current. Pharmacol. Ther. 107, 59-79 (2005).
4. Noam, Y., Bernard, C. & Baram, T. Z. Towards an integrated view of HCN channel role in epilepsy. Curr. Opin. Neurobiol. 20 Jun 2011 (doi:10.1016/j. conb.2011.06.013).
5. Lewis, A. S. & Chetkovich, D. M. HCN channels in behavior and neurological disease: too hyper or not active enough? Mol. Cell. Neurosci. 46, 357-367 (2011).
6. Dunlop, J., Vasilyev, D., Lu, P., Cummons, T. & Bowlby, M. R. Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels and pain. Curr. Pharm. Des. 15, 1767-1772 (2009).
7. Brown, H. F., DiFrancesco, D. & Noble, S. J. How does adrenaline accelerate the heart? Nature 280, 235-236 (1979).
8. Halliwell, J. V. & Adams, P. R. Voltage-clamp analysis of muscarinic excitation in hippocampal neurons. Brain Res. 250, 71-92 (1982).
9. Pape, H. C. Queer current and pacemaker: the hyperpolarization-activated cation current in neurons. Annu. Rev. Physiol. 58, 299-327 (1996).
10. Yu, F. H., Yarov-Yarovoy, V., Gutman, G. A. & Catterall, W. A. Overview of molecular relationships in the voltage-gated ion channel superfamily. Pharmacol. Rev. 57, 387-395 (2005).
11. Gauss, R., Seifert, R. & Kaupp, U. B. Molecular identification of a hyperpolarization-activated channel in sea urchin sperm. Nature 393, 583-587 (1998). This was the first study to report the cloning of an invertebrate HCN channel.
12. Ishii, T. M., Takano, M., Xie, L. H., Noma, A. & Ohmori, H. Molecular characterization of the hyperpolarization-activated cation channel in rabbit heart sinoatrial node. J. Biol. Chem. 274, 12835-12839 (1999).
13. Krieger, J., Strobel, J., Vogl, A., Hanke, W. & Breer, H. Identification of a cyclic nucleotide-and voltage - activated ion channel from insect antennae. Insect Biochem. Mol. Biol. 29, 255-267 (1999).
14. Ludwig, A., Zong, X., Jeglitsch, M., Hofmann, F. & Biel, M. A family of hyperpolarization-activated mammalian cation channels. Nature 393, 587-591 (1998). This was the first study to identify three members of the HCN channel family in a mouse brain.
15. Ludwig, A. et al. Two pacemaker channels from human heart with profoundly different activation kinetics. EMBO J. 18, 2323-2329 (1999).
16. Marx, T., Gisselmann, G., Stortkuhl, K. F., Hovemann, B. T. & Hatt, H. Molecular cloning of a putative voltage- and cyclic nucleotide-gated ion channel present in the antennae and eyes of Drosophila melanogaster. Invert. Neurosci. 4, 55-63 (1999).
17. Seifert, R. et al. Molecular characterization of a slowly gating human hyperpolarization-activated channel predominantly expressed in thalamus, heart, and testis. Proc. Natl Acad. Sci. USA 96, 9391-9396 (1999).
18. Santoro, B. et al. Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain. Cell 93, 717-729 (1998). This was the first study to report the cloning and functional expression of HCN1.
19. Santoro, B., Grant, S. G., Bartsch, D. & Kandel, E. R. Interactive cloning with the SH3 domain of N-src identifies a new brain specific ion channel protein, with homology to Eag and cyclic nucleotide-gated channels. Proc. Natl Acad. Sci. USA 94, 14815-14820 (1997).
20. Shi, W. et al. Distribution and prevalence of hyperpolarization-activated cation channel (HCN) mRNA expression in cardiac tissues. Circ. Res. 85, e1-e6 (1999).
21. Mannikko, R., Elinder, F. & Larsson, H. P. Voltage-sensing mechanism is conserved among ion channels gated by opposite voltages. Nature 419, 837-841 (2002).
22. Zagotta, W. N. et al. Structural basis for modulation and agonist specificity of HCN pacemaker channels. Nature 425, 200-205 (2003). This study reported the crystal structure of the CNBD-C-linker of HCN2.
23. Xu, X., Vysotskaya, Z. V., Liu, Q. & Zhou, L. Structural basis for the cAMP-dependent gating in the human HCN4 channel. J. Biol. Chem. 285, 37082-37091 (2010).
24. DiFrancesco, D. & Tortora, P. Direct activation of cardiac pacemaker channels by intracellular cyclic AMP. Nature 351, 145-147 (1991).
25. Wainger, B. J., DeGennaro, M., Santoro, B., Siegelbaum, S. A. & Tibbs, G. R. Molecular mechanism of cAMP modulation of HCN pacemaker channels. Nature 411, 805-810 (2001).
26. Mistrik, P. et al. The murine HCN3 gene encodes a hyperpolarization- activated cation channel with slow kinetics and unique response to cyclic nucleotides. J. Biol. Chem. 280, 27056-27061 (2005).
27. Ulens, C. & Tytgat, J. Functional heteromerization of HCN1 and HCN2 pacemaker channels. J. Biol. Chem. 276, 6069-6072 (2001).
28. Moosmang, S., Biel, M., Hofmann, F. & Ludwig, A. Differential distribution of four hyperpolarization-activated cation channels in mouse brain. Biol. Chem. 380, 975-980 (1999).
29. Monteggia, L. M., Eisch, A. J., Tang, M. D., Kaczmarek, L. K. & Nestler, E. J. Cloning and localization of the hyperpolarization-activated cyclic nucleotide-gated channel family in rat brain. Brain Res. Mol. Brain Res. 81, 129-139 (2000).
30. Santoro, B. et al. Molecular and functional heterogeneity of hyperpolarization-activated pacemaker channels in the mouse CNS. J. Neurosci. 20, 5264-5275 (2000).
31. Notomi, T. & Shigemoto, R. Immunohistochemical localization of Ih channel subunits, HCN1-4, in the rat brain. J. Comp. Neurol. 471, 241-276 (2004). This is an extensive immunohistochemistry study examining the expression pattern of all four HCN channels in the rat brain.
32. Moosmang, S. et al. Cellular expression and functional characterization of four hyperpolarization-activated pacemaker channels in cardiac and neuronal tissues. Eur. J. Biochem. 268, 1646-1652 (2001).
33. Fenske, S. et al. HCN3 contributes to the ventricular action potential waveform in the murine heart. Circ. Res. 109, 1015-1023 (2011).
34. Muller, F. et al. HCN channels are expressed differentially in retinal bipolar cells and concentrated at synaptic terminals. Eur. J. Neurosci. 17, 2084-2096 (2003).
35. Cho, H. J., Staikopoulos, V., Furness, J. B. & Jennings, E. A. Inflammation-induced increase in hyperpolarization-activated, cyclic nucleotide-gated channel protein in trigeminal ganglion neurons and the effect of buprenorphine. Neuroscience 162, 453-461 (2009).
36. Vasilyev, D. V. et al. Direct inhibition of Ih by analgesic loperamide in rat DRG neurons. J. Neurophysiol. 97, 3713-3721 (2007).
37. Tellez, J. O. et al. Differential expression of ion channel transcripts in atrial muscle and sinoatrial node in rabbit. Circ. Res. 99, 1384-1393 (2006).
38. Liu, J., Dobrzynski, H., Yanni, J., Boyett, M. R. & Lei, M. Organisation of the mouse sinoatrial node: structure and expression of HCN channels. Cardiovasc. Res. 73, 729-738 (2007).
39. Stieber, J. et al. The hyperpolarization-activated channel HCN4 is required for the generation of pacemaker action potentials in the embryonic heart. Proc. Natl Acad. Sci. USA 100, 15235-15240 (2003).
40. Baruscotti, M. et al. Deep bradycardia and heart block caused by inducible cardiac-specific knockout of the pacemaker channel gene Hcn4. Proc. Natl Acad. Sci. USA 108, 1705-1710 (2011).
41. Ludwig, A. et al. Absence epilepsy and sinus dysrhythmia in mice lacking the pacemaker channel HCN2. EMBO J. 22, 216-224 (2003). This report shows that deletion of HCN2 leads to absence epilepsy.
42. Cho, H. J., Furness, J. B. & Jennings, E. A. Post-natal maturation of the hyperpolarisation-activated cation current, Ih, in trigeminal sensory neurons. J. Neurophysiol. 106, 2045-2056 (2011).
43. Huang, X., Yang, P., Du, Y., Zhang, J. & Ma, A. Age-related down-regulation of HCN channels in rat sinoatrial node. Basic Res. Cardiol. 102, 429-435 (2007).
44. Surges, R. et al. Regulated expression of HCN channels and cAMP levels shape the properties of the h current in developing rat hippocampus. Eur. J. Neurosci. 24, 94-104 (2006).
45. Zolles, G. et al. Association with the auxiliary subunit PEX5R/Trip8b controls responsiveness of HCN channels to cAMP and adrenergic stimulation. Neuron 62, 814-825 (2009). This was a proteomic study on neuronal HCN channel complexes.
46. Santoro, B. et al. TRIP8b splice variants form a family of auxiliary subunits that regulate gating and trafficking of HCN channels in the brain. Neuron 62, 802-813 (2009).
47. Lewis, A. S. et al. Alternatively spliced isoforms of TRIP8b differentially control h channel trafficking and function. J. Neurosci. 29, 6250-6265 (2009).
48. Piskorowski, R., Santoro, B. & Siegelbaum, S. A. TRIP8b splice forms act in concert to regulate the localization and expression of HCN1 channels in CA1 pyramidal neurons. Neuron 70, 495-509 (2011).
49. Lipscombe, D. & Pan, J. Q. Tripping the HCN breaker. Neuron 62, 747-750 (2009).
50. Yu, H. et al. MinK-related peptide 1: a β subunit for the HCN ion channel subunit family enhances expression and speeds activation. Circ. Res. 88, e84-e87 (2001).
51. + channel regulator KCR1 suppresses heart rhythm by modulating the pacemaker current If. PLoS ONE 3, e1511 (2008).
52. Gravante, B. et al. Interaction of the pacemaker channel HCN1 with filamin A. J. Biol. Chem. 279, 43847-43853 (2004).
53. Kimura, K., Kitano, J., Nakajima, Y. & Nakanishi, S. Hyperpolarization-activated, cyclic nucleotide-gated HCN2 cation channel forms a protein assembly with multiple neuronal scaffold proteins in distinct modes of protein-protein interaction. Genes Cells 9, 631-640 (2004).
54. Barbuti, A., Terragni, B., Brioschi, C. & DiFrancesco, D. Localization of f-channels to caveolae mediates specific β2-adrenergic receptor modulation of rate in sinoatrial myocytes. J. Mol. Cell. Cardiol. 42, 71-78 (2007).
55. Pian, P., Bucchi, A., Robinson, R. B. & Siegelbaum, S. A. Regulation of gating and rundown of HCN hyperpolarization-activated channels by exogenous and endogenous PIP2. J. Gen. Physiol. 128, 593-604 (2006).
56. Zolles, G. et al. Pacemaking by HCN channels requires interaction with phosphoinositides. Neuron 52, 1027-1036 (2006).
57. Fogle, K. J., Lyashchenko, A. K., Turbendian, H. K. & Tibbs, G. R. HCN pacemaker channel activation is controlled by acidic lipids downstream of diacylglycerol kinase and phospholipase A2. J. Neurosci. 27, 2802-2814 (2007).
58. Frace, A. M., Maruoka, F. & Noma, A. Control of the hyperpolarization-activated cation current by external anions in rabbit sino-atrial node cells. J. Physiol. 453, 307-318 (1992).
59. Munsch, T. & Pape, H. C. Modulation of the hyperpolarization- activated cation current of rat thalamic relay neurones by intracellular pH. J. Physiol. 519 (Pt 2), 493-504 (1999).
60. Zong, X., Stieber, J., Ludwig, A., Hofmann, F. & Biel, M. A single histidine residue determines the pH sensitivity of the pacemaker channel HCN2. J. Biol. Chem. 276, 6313-6319 (2001).
61. Stevens, D. R. et al. Hyperpolarization-activated channels HCN1 and HCN4 mediate responses to sour stimuli. Nature 413, 631-635 (2001).
62. Wahl-Schott, C., Baumann, L., Zong, X. & Biel, M. An arginine residue in the pore region is a key determinant of chloride dependence in cardiac pacemaker channels. J. Biol. Chem. 280, 13694-13700 (2005).
63. Zong, X. et al. A novel mechanism of modulation of hyperpolarization- activated cyclic nucleotide-gated channels by Src kinase. J. Biol. Chem. 280, 34224-34232 (2005).
64. Arinsburg, S. S., Cohen, I. S. & Yu, H. G. Constitutively active Src tyrosine kinase changes gating of HCN4 channels through direct binding to the channel proteins. J. Cardiovasc. Pharmacol. 47, 578-586 (2006).
65. Poolos, N. P., Bullis, J. B. & Roth, M. K. Modulation of h-channels in hippocampal pyramidal neurons by p38 mitogen-activated protein kinase. J. Neurosci. 26, 7995-8003 (2006).
66. Jung, S. et al. Downregulation of dendritic HCN channel gating in epilepsy is mediated by altered phosphorylation signaling. J. Neurosci. 30, 6678-6688 (2010).
67. Hammelmann, V., Zong, X., Hofmann, F., Michalakis, S. & Biel, M. The cGMP-dependent protein kinase II is an inhibitory modulator of the hyperpolarization-activated HCN2 channel. PLoS ONE 6, e17078 (2011).
68. Baruscotti, M., Bottelli, G., Milanesi, R., DiFrancesco, J. C. & DiFrancesco, D. HCN-related channelopathies. Pflugers Arch. 460, 405-415 (2010). This paper provides an excellent overview of HCN channelopathies.
69. DiFrancesco, D. The role of the funny current in pacemaker activity. Circ. Res. 106, 434-446 (2010).
70. Cohen, I. S. & Robinson, R. B. Pacemaker current and automatic rhythms: toward a molecular understanding. Handb. Exp. Pharmacol. 171, 41-71 (2006).
71. Jiang, Y. Q., Sun, Q., Tu, H. Y. & Wan, Y. Characteristics of HCN channels and their participation in neuropathic pain. Neurochem. Res. 33, 1979-1989 (2008).
72. Poolos, N. P. The yin and yang of the H-channel and its role in epilepsy. Epilepsy Curr. 4, 3-6 (2004).
73. Schulze-Bahr, E. et al. Pacemaker channel dysfunction in a patient with sinus node disease. J. Clin. Invest. 111, 1537-1545 (2003).
74. Ueda, K. et al. Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia. J. Biol. Chem. 279, 27194-27198 (2004).
75. Milanesi, R., Baruscotti, M., Gnecchi-Ruscone, T. & DiFrancesco, D. Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel. N. Engl. J. Med. 354, 151-157 (2006).
76. Nof, E. et al. Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia. Circulation 116, 463-470 (2007).
77. Schweizer, P. A. et al. cAMP sensitivity of HCN pacemaker channels determines basal heart rate but is not critical for autonomic rate control. Circ. Arrhythm. Electrophysiol. 3, 542-552 (2010).
78. Laish-Farkash, A. et al. A novel mutation in the HCN4 gene causes symptomatic sinus bradycardia in moroccan jews. J. Cardiovasc. Electrophysiol. 21, 1365-1372 (2010).
79. Harzheim, D. et al. Cardiac pacemaker function of HCN4 channels in mice is confined to embryonic development and requires cyclic AMP. EMBO J. 27, 692-703 (2008).
80. Herrmann, S., Stieber, J., Stockl, G., Hofmann, F. & Ludwig, A. HCN4 provides a 'depolarization reserve' and is not required for heart rate acceleration in mice. EMBO J. 26, 4423-4432 (2007).
81. Hoesl, E. et al. Tamoxifen-inducible gene deletion in the cardiac conduction system. J. Mol. Cell. Cardiol. 45, 62-69 (2008).
82. Cerbai, E. & Mugelli, A. If in non-pacemaker cells: role and pharmacological implications. Pharmacol. Res. 53, 416-423 (2006).
83. Mangoni, M. E. & Nargeot, J. Genesis and regulation of the heart automaticity. Physiol. Rev. 88, 919-982 (2008).
84. Stillitano, F. et al. Molecular basis of funny current (If) in normal and failing human heart. J. Mol. Cell. Cardiol. 45, 289-299 (2008).
85. Campbell, J. N. & Meyer, R. A. Mechanisms of neuropathic pain. Neuron 52, 77-92 (2006).
86. Bender, R. A. & Baram, T. Z. Hyperpolarization activated cyclic-nucleotide gated (HCN) channels in developing neuronal networks. Prog. Neurobiol. 86, 129-140 (2008). This report shows that developmental HCN channel dysregulation has a role in the generation of epilepsies.
87. Chaplan, S. R. et al. Neuronal hyperpolarization-activated pacemaker channels drive neuropathic pain. J. Neurosci. 23, 1169-1178 (2003). This study links upregulation of HCN channels with peripheral neuropathies.
88. Kitagawa, J. et al. Mechanisms involved in modulation of trigeminal primary afferent activity in rats with peripheral mononeuropathy. Eur. J. Neurosci. 24, 1976-1986 (2006).
89. Doan, T. N. et al. Differential distribution and function of hyperpolarization-activated channels in sensory neurons and mechanosensitive fibers. J. Neurosci. 24, 3335-3343 (2004).
90. Dyhrfjeld-Johnsen, J., Morgan, R. J. & Soltesz, I. Double trouble? Potential for hyperexcitability following both channelopathic up- and downregulation of Ih in epilepsy. Front. Neurosci. 3, 25-33 (2009).
91. Benetos, A., Rudnichi, A., Thomas, F., Safar, M. & Guize, L. Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure. Hypertension 33, 44-52 (1999).
92. Yusuf, S. & Camm, A. J. Sinus tachyarrhythmias and the specific bradycardic agents: a marriage made in heaven? J. Cardiovasc. Pharmacol. Ther. 8, 89-105 (2003).
93. Borer, J. S. Drug insight: If inhibitors as specific heart-rate-reducing agents. Nature Clin. Pract. Cardiovasc. Med. 1, 103-109 (2004).
94. Levine, H. J. Rest heart rate and life expectancy. J. Am. Coll. Cardiol. 30, 1104-1106 (1997).
95. Doesch, A. O. et al. Heart rate reduction after heart transplantation with β-blocker versus the selective If channel antagonist ivabradine. Transplantation 84, 988-996 (2007).
96. Bois, P., Guinamard, R., Chemaly, A. E., Faivre, J. F. & Bescond, J. Molecular regulation and pharmacology of pacemaker channels. Curr. Pharm. Des. 13, 2338-2349 (2007).
97. Bucchi, A., Baruscotti, M. & DiFrancesco, D. Current-dependent block of rabbit sino-atrial node If channels by ivabradine. J. Gen. Physiol. 120, 1-13 (2002). This study examines the molecular mechanism of action of ivabradine.
98. Bucchi, A., Tognati, A., Milanesi, R., Baruscotti, M. & DiFrancesco, D. Properties of ivabradine-induced block of HCN1 and HCN4 pacemaker channels. J. Physiol. 572, 335-346 (2006).
99. Riccioni, G., Vitulano, N. & D'Orazio, N. Ivabradine: beyond heart rate control. Adv. Ther. 26, 12-24 (2009).
100. Cerbai, E. et al. Characterization of the hyperpolarization-activated current, If, in ventricular myocytes from human failing heart. Circulation 95, 568-571 (1997).
101. Hoppe, U. C. et al. Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure. Circulation 114, 18-25 (2006).
102. Manz, M., Reuter, M., Lauck, G., Omran, H. & Jung, W. A single intravenous dose of ivabradine, a novel If inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction. Cardiology 100, 149-155 (2003).
103. Fox, K., Ford, I., Steg, P. G., Tendera, M. & Ferrari, R. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372, 807-816 (2008). This study reported the results of a large clinical trial (BEAUTIFUL) of ivabradine.
104. Fox, K. et al. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 372, 817-821 (2008).
105. Swedberg, K. et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376, 875-885 (2010). This study reported the results of a clinical trial (SHIFT) of ivabradine.
106. Melchiorre, M. et al. Design, synthesis, and preliminary biological evaluation of new isoform-selective f-current blockers. J. Med. Chem. 53, 6773-6777 (2010). This was the first report on the attempts to design subtype-specific HCN channel blockers.
107. Bois, P., Bescond, J., Renaudon, B. & Lenfant, J. Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells. Br. J. Pharmacol. 118, 1051-1057 (1996).
108. DiFrancesco, D. & Camm, J. A. Heart rate lowering by specific and selective If current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. Drugs 64, 1757-1765 (2004).
109. Stieber, J. Ivabradine: pharmacodynamic aspects of its clinical use. Methods Find. Exp. Clin. Pharmacol. 30, 633-641 (2008).
110. Barrow, A. J. & Wu, S. M. Low-conductance HCN1 ion channels augment the frequency response of rod and cone photoreceptors. J. Neurosci. 29, 5841-5853 (2009).
111. Cervetto, L., Demontis, G. C. & Gargini, C. Cellular mechanisms underlying the pharmacological induction of phosphenes. Br. J. Pharmacol. 150, 383-390 (2007).
112. Romanelli, M. N. et al. Isoform-selective HCN blockers. WO Patent 2011/000915 (2011).
113. Savelieva, I. & Camm, A. J. If inhibition with ivabradine: electrophysiological effects and safety. Drug Saf. 31, 95-107 (2008).
114. Knaus, A. et al. Direct inhibition of cardiac hyperpolarization-activated cyclic nucleotide-gated pacemaker channels by clonidine. Circulation 115, 872-880 (2007). This is a report on the effects of clonidine on HCN channels.
115. Huang, Z., Walker, M. C. & Shah, M. M. Loss of dendritic HCN1 subunits enhances cortical excitability and epileptogenesis. J. Neurosci. 29, 10979-10988 (2009).
116. Santoro, B. et al. Increased seizure severity and seizure-related death in mice lacking HCN1 channels. Epilepsia 51, 1624-1627 (2010).
117. Shah, M. M., Anderson, A. E., Leung, V., Lin, X. & Johnston, D. Seizure-induced plasticity of h channels in entorhinal cortical layer III pyramidal neurons. Neuron 44, 495-508 (2004).
118. Shin, M., Brager, D., Jaramillo, T. C., Johnston, D. & Chetkovich, D. M. Mislocalization of h channel subunits underlies h channelopathy in temporal lobe epilepsy. Neurobiol. Dis. 32, 26-36 (2008).
119. Dibbens, L. M. et al. Augmented currents of an HCN2 variant in patients with febrile seizure syndromes. Ann. Neurol. 67, 542-546 (2010).
120. Richichi, C. et al. Mechanisms of seizure-induced 'transcriptional channelopathy' of hyperpolarization-activated cyclic nucleotide gated (HCN) channels. Neurobiol. Dis. 29, 297-305 (2008).
121. Kitayama, M. et al. Ih blockers have a potential of antiepileptic effects. Epilepsia 44, 20-24 (2003).
122. Poolos, N. P., Migliore, M. & Johnston, D. Pharmacological upregulation of h-channels reduces the excitability of pyramidal neuron dendrites. Nature Neurosci. 5, 767-774 (2002).
123. Surges, R., Freiman, T. M. & Feuerstein, T. J. Gabapentin increases the hyperpolarization-activated cation current Ih in rat CA1 pyramidal cells. Epilepsia 44, 150-156 (2003).
124. Luo, L. et al. Role of peripheral hyperpolarization-activated cyclic nucleotide-modulated channel pacemaker channels in acute and chronic pain models in the rat. Neuroscience 144, 1477-1485 (2007).
125. Descoeur, J. et al. Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors. EMBO Mol. Med. 3, 266-278 (2011). This study demonstrates that HCN channels are potential targets for the treatment of oxaliplatin-induced cold hypersensitivity.
126. Momin, A., Cadiou, H., Mason, A. & McNaughton, P. A. Role of the hyperpolarization-activated current Ih in somatosensory neurons. J. Physiol. 586, 5911-5929 (2008).
127. Emery, E. C., Young, G. T., Berrocoso, E. M., Chen, L. & McNaughton, P. A. HCN2 ion channels play a central role in inflammatory and neuropathic pain. Science 333, 1462-1466 (2011).
128. Lee, D. H., Chang, L., Sorkin, L. S. & Chaplan, S. R. Hyperpolarization-activated, cation-nonselective, cyclic nucleotide-modulated channel blockade alleviates mechanical allodynia and suppresses ectopic discharge in spinal nerve ligated rats. J. Pain 6, 417-424 (2005).
129. Sun, Q., Xing, G. G., Tu, H. Y., Han, J. S. & Wan, Y. Inhibition of hyperpolarization-activated current by ZD7288 suppresses ectopic discharges of injured dorsal root ganglion neurons in a rat model of neuropathic pain. Brain Res. 1032, 63-69 (2005).
130. Yagi, J. & Sumino, R. Inhibition of a hyperpolarization-activated current by clonidine in rat dorsal root ganglion neurons. J. Neurophysiol. 80, 1094-1104 (1998).
131. Rudolph, U. & Antkowiak, B. Molecular and neuronal substrates for general anaesthetics. Nature Rev. Neurosci. 5, 709-720 (2004).
132. Linden, A. M. et al. TASK-3 knockout mice exhibit exaggerated nocturnal activity, impairments in cognitive functions, and reduced sensitivity to inhalation anesthetics. J. Pharmacol. Exp. Ther. 323, 924-934 (2007).
133. Sirois, J. E., Pancrazio, J. J., Iii, C. L. & Bayliss, D. A. Multiple ionic mechanisms mediate inhibition of rat motoneurones by inhalation anaesthetics. J. Physiol. 512 (Pt 3), 851-862 (1998).
134. Sirois, J. E., Lynch, C. & Bayliss, D. A. Convergent and reciprocal modulation of a leak K+ current and Ih by an inhalational anaesthetic and neurotransmitters in rat brainstem motoneurones. J. Physiol. 541, 717-729 (2002).
135. Budde, T. et al. Reciprocal modulation of Ih and ITASK in thalamocortical relay neurons by halothane. Pflugers Arch. 456, 1061-1073 (2008).
136. Chen, X. et al. HCN subunit-specific and cAMP-modulated effects of anesthetics on neuronal pacemaker currents. J. Neurosci. 25, 5803-5814 (2005).
137. Chen, X., Shu, S., Kennedy, D. P., Willcox, S. C. & Bayliss, D. A. Subunit-specific effects of isoflurane on neuronal Ih in HCN1 knockout mice. J. Neurophysiol. 101, 129-140 (2009). This study shows that general anaesthetics target HCN channels.
138. Cacheaux, L. P. et al. Impairment of hyperpolarization-activated, cyclic nucleotide-gated channel function by the intravenous general anesthetic propofol. J. Pharmacol. Exp. Ther. 315, 517-525 (2005).
139. Meng, Q. T., Xia, Z. Y., Liu, J., Bayliss, D. A. & Chen, X. Local anesthetic inhibits hyperpolarization-activated cationic currents. Mol. Pharmacol. 79, 866-873 (2011).
140. Griguoli, M. et al. Nicotine blocks the hyperpolarization-activated current Ih and severely impairs the oscillatory behavior of oriens-lacunosum moleculare interneurons. J. Neurosci. 30, 10773-10783 (2010).
141. Knop, G. C. et al. Light responses in the mouse retina are prolonged upon targeted deletion of the HCN1 channel gene. Eur. J. Neurosci. 28, 2221-2230 (2008).
142. Moroni, A. et al. Hyperpolarization-activated cyclic nucleotide-gated channel 1 is a molecular determinant of the cardiac pacemaker current If. J. Biol. Chem. 276, 29233-29241 (2001).
143. Marionneau, C. et al. Specific pattern of ionic channel gene expression associated with pacemaker activity in the mouse heart. J. Physiol. 562, 223-234 (2005).
144. Hurtado, R., Bub, G. & Herzlinger, D. The pelvis-kidney junction contains HCN3, a hyperpolarization-activated cation channel that triggers ureter peristalsis. Kidney Int. 77, 500-508 (2010).
145. Dobrzynski, H. et al. Site of origin and molecular substrate of atrioventricular junctional rhythm in the rabbit heart. Circ. Res. 93, 1102-1110 (2003).
146. McClure, K. J. et al. Discovery of a novel series of selective HCN1 blockers. Bioorg. Med. Chem. Lett. 21, 5197-5201 (2011).